Bassiouny, Eglal A.
El-Samanoudy, Solwan I.
Abbassi, Maggie M.
Nada, Hanan R.
Farid, Samar F.
Funding for this research was provided by:
Cairo University
Article History
Received: 22 August 2022
Revised: 13 November 2022
Accepted: 5 December 2022
First Online: 26 December 2022
Declarations
:
: The authors declare no competing interests.
: None declared.
: This study was performed in line with the principles of the Declaration of Helsinki, and the study protocol (CL 2555) was approved by the Research Ethics Committee for Experimental and Clinical Studies, Faculty of Pharmacy, Cairo University. The study was registered in clinicaltrials.gov, identifier number NCT04481412.
: Oral and written informed consents were obtained from all patients before enrollment.